Buy Tirzepatide 7.5mg (R&D Only)
Tirzepatide 7.5mg is a high-purity research peptide supplied exclusively for scientific and laboratory applications. As a next-generation dual receptor agonist, Tirzepatide has become one of the most important compounds in peptide science due to its ability to simultaneously target GLP-1 and GIP receptors.
Its advanced molecular structure allows researchers to investigate complex biological signalling pathways, receptor interactions, and metabolic communication systems within controlled laboratory environments.
Tirzepatide continues to attract significant interest across biotechnology, pharmaceutical development, endocrinology, and metabolic research due to its innovative dual-receptor profile and broad scientific applications.
What Is Tirzepatide?
Tirzepatide is a synthetic peptide engineered to activate two important receptor pathways involved in metabolic and endocrine signalling:
- GLP-1 (Glucagon-Like Peptide-1) Receptors
- GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptors
Unlike traditional single-target research peptides, Tirzepatide’s dual-agonist activity enables researchers to examine multiple receptor systems simultaneously.
This unique mechanism has established Tirzepatide as one of the most recognised compounds in modern peptide research.
Key Features
High-Purity 7.5mg Formula
Each vial contains:
- 7.5mg Tirzepatide
- Research Grade Quality
- High-Purity Peptide Content
- Lyophilised Powder Format
Dual Receptor Agonist
Tirzepatide simultaneously targets:
- GLP-1 Receptors
- GIP Receptors
allowing researchers to investigate multiple biological signalling pathways within a single research model.
Research Grade Manufacturing
Produced under stringent quality-control standards to ensure purity, consistency, and laboratory reliability.
Suitable for Advanced Scientific Research
Frequently utilised in:
- Metabolic pathway studies
- Endocrine investigations
- Receptor pharmacology
- Peptide development
- Stability testing
- Formulation optimisation
Research Applications
Metabolic Signalling Research
Tirzepatide is widely utilised in studies involving metabolic regulation, cellular signalling pathways, and receptor-mediated biological responses.
GLP-1 Receptor Investigations
Researchers use Tirzepatide to study receptor activation, signalling mechanisms, and peptide-receptor interactions associated with GLP-1 pathways.
GIP Receptor Studies
The peptide is commonly included in research involving GIP receptor activity and biological communication systems.
Peptide Pharmacology
Suitable for studies involving:
- Receptor affinity analysis
- Biological activity assessment
- Pharmacodynamic evaluation
- Stability investigations
Endocrine Research
Researchers frequently utilise Tirzepatide to explore hormonal signalling systems and receptor communication pathways.
Research Formulation Development
Applicable for:
- Compound optimisation
- Delivery system research
- Stability testing
- Product development projects
Why Choose Tirzepatide 7.5mg?
Advanced Dual Agonist Technology
Tirzepatide remains one of the most sophisticated research peptides available for metabolic and endocrine investigations.
Significant Scientific Interest
Its ability to activate both GLP-1 and GIP receptors has generated widespread attention throughout peptide science and biotechnology research.
Premium Research Quality
Manufactured according to rigorous laboratory standards to support reliable and reproducible research outcomes.
Broad Research Potential
Suitable across multiple scientific disciplines including:
- Metabolic biology
- Endocrinology
- Receptor science
- Peptide pharmacology
- Cellular signalling studies
- Drug development research
Storage Information
For optimal stability:
- Store refrigerated at 2°C–8°C
- Protect from direct sunlight
- Avoid excessive heat exposure
- Keep vial tightly sealed
- Follow standard laboratory handling protocols
Proper storage helps preserve peptide integrity and long-term research quality.
Important Disclaimer
This product is supplied strictly for Research & Development purposes only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of disease. All handling should be conducted by qualified professionals in controlled laboratory environments.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Tirzepatide 7.5mg |
| Active Ingredient | Tirzepatide |
| Strength | 7.5mg |
| Format | Lyophilised Powder |
| Category | Dual Agonist Research Peptide |
| Targets | GLP-1 & GIP Receptors |
| Grade | Research Grade |
| Storage | 2°C–8°C |
| Application | Research Use Only |
Frequently Asked Questions
What is Tirzepatide 7.5mg?
Tirzepatide 7.5mg is a research-grade dual agonist peptide developed for laboratory investigations involving GLP-1 and GIP receptor pathways.
Why is Tirzepatide considered a dual agonist?
Tirzepatide simultaneously activates GLP-1 and GIP receptors, allowing researchers to investigate multiple biological signalling pathways using a single compound.
What research areas commonly use Tirzepatide?
Researchers frequently utilise Tirzepatide in metabolic studies, endocrine research, receptor pharmacology, peptide science, and formulation development.
What format is Tirzepatide supplied in?
The product is supplied as a high-purity lyophilised peptide powder suitable for laboratory applications.
How should Tirzepatide be stored?
Store refrigerated between 2°C and 8°C while protecting the product from heat, moisture, and direct sunlight.
Is Tirzepatide intended for human use?
No. This product is supplied exclusively for research and development purposes.




Reviews
There are no reviews yet.